Zhang A, Gong B, Liu Y, Zhang G, Zhou C, Li S, Guo C, Yang H, Li Y, Wang L, Zhang B, Wei H, Wang J, Qiu S. Durable deep molecular response via CD19 chimeric antigen receptor T-cell therapy combined with a third-generation tyrosine kinase inhibitor in acute leukemia of ambiguous lineage with the Philadelphia chromosome: a potential strategy for transplant-ineligible patients. Haematologica; https://doi.org/10.3324/haematol.2026.300521 [Early view].